SciDevL (SDV) Q1 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 TU earnings summary
13 Jun, 2025Executive summary
Revenue for Q1 FY25 reached $26.1m, a 21% increase year-over-year, with strong contributions from both Chemical Services and Water Technologies.
Underlying EBITDA was $2.7m, up 286% compared to Q1 FY24, and operating cash flow was positive at $1.4m.
Cash and cash equivalents at quarter-end were $10.2m, up from $9.4m at June 30, 2024.
Gross margin for the period was 29%, driven by proprietary chemistry sales in US Oilfield and domestic mining.
Financial highlights
Revenue of $26.1m, up 21% year-over-year; cash receipts from customers matched revenue.
Underlying EBITDA of $2.7m, a 286% increase year-over-year.
Positive operating cash flow of $1.4m for the quarter.
Cash and cash equivalents at quarter-end were $10.2m, with $6.1m in inventory.
Gross margin was 29% for the quarter.
Outlook and guidance
Management expects continued growth across all business units, with momentum from Q1 anticipated to carry through FY25.
Slight seasonal downturn expected in Q2 FY25 before activity picks up in January.
Ongoing expansion in US Oil & Gas and international mining markets, leveraging proprietary technologies.
Strong domestic pipeline in Water Technologies and positive progress in US & European PFAS markets.
Latest events from SciDevL
- Revenue and EBITDA declined, but recurring revenue and cost actions support future growth.SDV
H1 202625 Feb 2026 - EBITDA rose to $3.4m on steady $49.9m revenue, with strong cash and PFAS-driven growth outlook.SDV
H1 202526 Dec 2025 - $103m revenue, margin gains, and global PFAS growth set up strong FY 2026 outlook.SDV
H2 202523 Nov 2025 - Revenue and EBITDA surged, with strategic US wins and strong demand despite market volatility.SDV
Q3 2025 TU16 Jun 2025 - FY24 saw double-digit growth and strategic expansion in water, mining, and PFAS solutions.SDV
AGM 2024 Presentation13 Jun 2025 - Record revenue, profit, and cash flow position SciDev for continued growth in FY25.SDV
H2 202413 Jun 2025 - Record revenue and EBITDA growth driven by PFAS demand and major contract wins.SDV
Q4 2024 TU13 Jun 2025